Literature DB >> 16955278

Regression of left ventricular hypertrophy in children with antihypertensive therapy.

Prema Ramaswamy1, Irene D Lytrivi, Chikku Paul, Mary Golden, Juan C Kupferman.   

Abstract

Left ventricular hypertrophy (LVH) is a complication of hypertension that has received great attention in the adult population. Large-scale randomized control studies in adults have demonstrated that LVH regresses in response to pharmacologic intervention. While it is known that LVH occurs as a complication of hypertension in the pediatric population, few studies have focused on its regression with pharmacological intervention. We report on three cases of hypertension-induced LVH in the pediatric population and its regression after treatment with antihypertensive medications. This report brings to light the need for larger, prospective studies on the incidence, natural history, and treatment of LVH associated with hypertension in the pediatric population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16955278     DOI: 10.1007/s00467-006-0291-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

Review 1.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Authors:  Arnfried U Klingbeil; Markus Schneider; Peter Martus; Franz H Messerli; Roland E Schmieder
Journal:  Am J Med       Date:  2003-07       Impact factor: 4.965

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 3.  Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy.

Authors:  J M Cruickshank; J Lewis; V Moore; C Dodd
Journal:  J Hum Hypertens       Date:  1992-04       Impact factor: 3.012

4.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

5.  Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy.

Authors:  H Schunkert; H W Hense; S R Holmer; M Stender; S Perz; U Keil; B H Lorell; G A Riegger
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

6.  Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.

Authors:  G de Simone; R B Devereux; S R Daniels; M J Koren; R A Meyer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1995-04       Impact factor: 24.094

7.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

Authors:  G de Simone; S R Daniels; R B Devereux; R A Meyer; M J Roman; O de Divitiis; M H Alderman
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

8.  The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the International Pediatric Hypertension Association.

Authors:  Coral Hanevold; Jennifer Waller; Stephen Daniels; Ronald Portman; Jonathan Sorof
Journal:  Pediatrics       Date:  2004-02       Impact factor: 7.124

9.  Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure.

Authors:  Jonathan M Sorof; Andrei V Alexandrov; Gina Cardwell; Ronald J Portman
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

10.  Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; D Levy
Journal:  J Am Coll Cardiol       Date:  1991-11-01       Impact factor: 24.094

View more
  6 in total

1.  Improvement of left ventricular mass with antihypertensive therapy in children with hypertension.

Authors:  Juan C Kupferman; Kara Paterno; Joseph Mahgerefteh; Murali Pagala; Meg Golden; Irene D Lytrivi; Prema Ramaswamy
Journal:  Pediatr Nephrol       Date:  2010-08       Impact factor: 3.714

2.  Change in cardiac geometry and function in CKD children during strict BP control: a randomized study.

Authors:  Maria Chiara Matteucci; Marcello Chinali; Gabriele Rinelli; Elke Wühl; Aleksandra Zurowska; Marina Charbit; Giacomo Pongiglione; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2012-11-02       Impact factor: 8.237

3.  The predictive value of repeated blood pressure measurements in childhood for cardiovascular risk in adults: the Hanzhong Adolescent Hypertension Study.

Authors:  Yue-Yuan Liao; Qiong Ma; Chao Chu; Yang Wang; Wen-Ling Zheng; Jia-Wen Hu; Yu Yan; Ke-Ke Wang; Yue Yuan; Chen Chen; Jian-Jun Mu
Journal:  Hypertens Res       Date:  2020-06-03       Impact factor: 3.872

4.  Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2007-11-29       Impact factor: 1.655

Review 5.  Hypertension in pediatric patients with chronic kidney disease: management challenges.

Authors:  Claire M Gallibois; Natasha A Jawa; Damien G Noone
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-07-26

6.  C-reactive protein and incident left ventricular hypertrophy in essential hypertension.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2007-06-11       Impact factor: 1.838

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.